Sponsor or institution
Clinical trials and research at Shenyang Northern Hospital
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Shenyang Northern Hospital that are recruiting, in China. By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pulsed field ablation for AF: isolated Superior Vena Cava plus Pulmonary Vein isolation | — | Chengdu, Sichuan | Recruiting | Jul 24, 2026 |
| Precision colchicine to target atherosclerosis in people with TET2-CHIP after ACS | Phase 4 | Shenyang, Liaoning | Recruiting | Jan 23, 2026 |
| Dapagliflozin for Coronary Inflammation in Stage 4 CKM Syndrome After ACS | Phase 4 | Shenyang, Liaoning | Recruiting | Jan 20, 2026 |
| AI-guided early thrombolysis for people with STEMI | — | Shenyang, Liaoning | Recruiting | Sep 8, 2025 |
| Outcomes for people hospitalized with coronary artery disease | — | Shenyang, Liaoning | Recruiting | Jan 22, 2024 |
| OPT-CAD–guided timing for switching to a P2Y12 inhibitor alone after PCI in acute coronary syndrome | — | Shenyang, Liaoning | Recruiting | Jan 22, 2024 |
All recruiting trials (6)
-
Pulsed field ablation for AF: isolated Superior Vena Cava plus Pulmonary Vein isolation
This study tests a pulsed field ablation approach to treat atrial fibrillation by isolating the pulmonary veins and the superior vena cava in adults who have not responded well to standard medications.
-
Precision colchicine to target atherosclerosis in people with TET2-CHIP after ACS
This study tests whether including colchicine helps post-ACS patients, guided by TET2-CHIP status, to reduce plaque growth.
-
Dapagliflozin for Coronary Inflammation in Stage 4 CKM Syndrome After ACS
This trial tests whether daily dapagliflozin can lower heart artery inflammation and slow plaque growth in adults with stage 4 CKM syndrome after acute coronary syndrome.
-
AI-guided early thrombolysis for people with STEMI
This trial tests whether an AI-assisted mobile app can help clinicians give earlier thrombolysis (plus planned PCI) for adults with STEMI who are unlikely to have the lesion opened within 120 minutes.
-
Outcomes for people hospitalized with coronary artery disease
This project will see how diagnostic tests and real-world treatment choices relate to outcomes for adults hospitalized with confirmed or suspected coronary heart disease.
-
OPT-CAD–guided timing for switching to a P2Y12 inhibitor alone after PCI in acute coronary syndrome
This trial will try using the OPT-CAD score to decide whether people with acute coronary syndrome can switch from dual antiplatelet therapy to a single P2Y12 drug after 1 or 3 months following stent placement.
Quick answers
How many clinical trials run by Shenyang Northern Hospital are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.